In this study, we investigated whether the tumor promoters, 12-O-tetradecanoylphorbol-13-acetate (TPA), phenobarbital (PB), and 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane (DDT), inhibited gap junctional intercellular communication (GJIC) in a cell-specific or connexin-specific manner and whether protein kinase C was involved. To do this, we used highly communicating WB-F344 rat liver epithelial cells, which express connexin43 as their predominant gap junction protein, WB-aB1 cells, which are a GJIC-incompetent mutant line of WB-F344 cells and that express connexin43, WB-a/32-10 cells, which are a highly communicating derivative of WB-aB1 cells generated by stable transduction with a connexin32 retroviral expression vector, and primary cultured rat hepatocytes, which express conexin32 predominantly. Treatment of WB-F344 and WBa/32-10 cells, but not hepatocytes, with TPA inhibited GJIC (assayed by Lucifer Yellow dye microinjection). This inhibition involved protein kinase C because (i) inhibition was prevented by co-treatment of the cells with a specific protein kinase C inhibitor, bis-indolylmaleimide, and (ii) treatment with TPA for 24 h had no effect on dyecoupling in agreement with the downregulation of protein kinase C. TPA also caused the internalization of Cx43-containing gap junctions and the formation of a hyperphosphorylated form of Cx43, Cx43-P3, in WB-F344 cells only, but TPA had no effect on Cx32-containing gap junctions or protein mobility. In contrast, PB inhibited GJIC only in hepatocytes and DDT inhibited GJIC in all three types of cells; bis-indolylmaleimide did not block the effects of either agent. These results indicate that the inhibitory actions of TPA and PB on GJIC are cell-specific rather than connexin-specific and that TPA inhibits connexin43 and connexin32-mediated GJIC through a protein kinase C-dependent mechanism.
Introduction
Gap junctions are clusters of channels formed by proteins known as connexins. At least 13 mammalian connexins have been cloned and they are expressed in a cell and developmentalspecific manner (1) . Gap junction channels have a pore size of~1.5-2 nm and permit small molecules and ions Ͻ1000 daltons to pass directly between adjacent cells (2) . This exchange, known as gap junctional intercellular communication (GJIC*), is involved in cellular growth regulation, differentiation and neoplastic transformation, possibly through the junctional transfer of unknown regulatory factors (2) . Gap junction number and connexin gene expression are frequently reduced in neoplastic cells (2, 3) . Many carcinogenic agents, most notably tumor promoters, reduce gap junction channel permeability, gap junction number and connexin expression in vivo and in vitro (3) (4) (5) (6) .
Yotti et al. (7) and Murray and Fitzgerald (8) were the first to report that tumor promoting agents, specifically phorbol esters, reduced GJIC in cultured cells. Since then, many studies have shown that most tumor promoters are capable of inhibiting GJIC in vitro and in vivo (3) (4) (5) . In many cases, however, tumor promoters exhibit cell-specific effects. For example, the skin tumor promoting phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), and the bladder tumor promoter, saccharin, inhibited GJIC in cultured fibroblasts and epithelial cells, but had little or no effect on GJIC in primary cultured hepatocytes (7) (8) (9) (10) (11) . In contrast, the liver tumor promoter, phenobarbital (PB), inhibited GJIC in hepatocytes, but had no effect on GJIC in fibroblasts or liver epithelial cells (11) (12) (13) . Because most epithelial cells and fibroblasts express connexin43 (Cx43) and hepatocytes express connexin32 (Cx32) as their predominant junctional proteins, these cellspecific effects of promoters could be due to differences in the type of connexin(s) expressed. Alternatively, other differences such as promoter metabolism or effects on signal transduction pathways could be involved. The inhibition of GJIC by phorbol esters in Cx43-expressing cells has been attributed to phosphorylation of this protein by protein kinase C (14, 15) . In contrast, phorbol esters also induce protein kinase C-mediated phosphorylation of Cx32 in hepatocytes and this appears to decrease Cx32 degradation and to enhance GJIC (16) (17) (18) (19) .
In this study, we investigated whether the tumor promoters, TPA, PB and 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane (DDT), exhibited cell-specific and/or connexin-specific inhibitory effects on hepatic cell GJIC. To do this, we used highly communicating WB-F344 rat liver epithelial cells, which express connexin43 as their predominant gap junction protein (14) , WB-aB1 cells, which are a GJIC-incompetent mutant line of WB-F344 cells and that expresses connexin43 (20), WBa/32-10 cells, which are a highly communicating derivative of WB-aB1 cells generated by stable transduction with a connexin32 retroviral expression vector (21) , and primary cultured rat hepatocytes, which express connexin32 predominantly (13) . We demonstrate that the inhibition of GJIC by these agents was dependent upon the cell type rather than the type of connexin expressed and that protein kinase C was involved in the inhibition of Cx43-mediated and Cx32-mediated GJIC by TPA in WB-F344 and WB-a/32-10 cells. (25) . Recombinant retrovirus was produced as described (26) . WBaB1 cells were infected with LXSNCx32. Retrovirally-transduced cells were selected by culturing in the presence of G418 (0.4 mg/ml) for 4 weeks and several independent clones were isolated. The properties of these clones are described elsewhere (21) . One clone, WB-a/32-10, with the highest level of Cx32 expression and GJIC was utilized in this study.
Materials and methods

Reagents
Hepatocytes were isolated from male F344 rats (150-200 g; Charles River Laboratories; Wilmington, MA) by two-stage collagenase perfusion of the liver as described (12) . Hepatocytes were plated at a density of 5ϫ10 4 viable cells/cm 2 in Leibovitz's L-15 medium supplemented with glucose (1 mg/ml), FBS (10%), gentamicin sulfate (40 µg/ml) and dexamethasone (1 µM). The cells were allowed to attach for 2 h, then refed with fresh medium. At 24 h later, the cells were treated with various tumor promoters by replacing their medium with fresh medium containing the promoter at the desired concentration and GJIC or other assays were then performed.
Assay of GJIC by dye microinjection
GJIC was assayed by microinjection of gap junction permeable fluorescent tracer Lucifer Yellow CH as described (12, 13) . GJIC, as reported in the figures, was defined as the percentage of first order neighbors that became fluorescent within 5 min after microinjecting the test cells. Ten cells per 3.5-cm dish were injected and at least three dishes per treatment regime were used. Groups were compared statistically by analysis of variance and Dunnett's post-hoc t-test (27) .
Connexin expression studies
Northern and Western blot analyses of connexin expression were performed as described (13) . Northern blots were probed using Cx43, Cx32 or Cx26 full-length cDNA probes (22) (23) (24) radiolabeled by random priming and Western blots were probed with mouse anti-connexin monoclonal antibodies (Zymed). Immunostaining was performed using connexin-specific monoclonal antibodies (13) . Figures 1 and 2 show the level of GJIC in WB-F344, WBaB1 and WB-a/32-10 cells, and in primary cultured rat hepatocytes. While no GJIC was detected in WB-aB1 cells, high levels were detected in WB-F344, WB-a/32-10 and hepatocytes (Figures 1 and 2 ). Thus, transduction of WB-aB1 cells with the recombinant retrovirus, LXSNRCx32, restored GJIC to a level comparable to wild-type WB-F344 cells and primary cultured rat hepatocytes.
Results
TPA effects on dye-coupling
In highly communicating WB-F344 and WB-a/32-10 cells, treatment with TPA (20 nM, 2 h) strongly inhibited GJIC, but in primary cultured hepatocytes TPA had no effect ( Figure 2 ). Because the inability of TPA to inhibit hepatocyte GJIC might be due to TPA hydrolysis, we investigated whether a higher concentration of TPA (200 nM) and shorter treatment durations (5, 15 and 30 min) blocked hepatocyte GJIC. None of these , WB-a/32-10 (E,F) and primary cultured F344 rat hepatocytes (G,H) were microinjected with Lucifer Yellow (*) as described in Materials and methods. Phase contrast (left panels) and fluorescence (right panels) photomicrographs were taken at ϫ20 magnification using a Nikon Diaphot epifluorescence microscope. Note that all cell types except WB-aB1 communicate extensively.
conditions affected hepatocyte GJIC; dye-coupling levels in these cells ranged between 90.2-96.4%.
Because inhibition of GJIC by TPA in WB-F344 cells has been attributed to the activation of protein kinase C (8), we investigated whether the kinase was involved in mediating such an effect in WB-F344 and WB-a/32-10 cells. Prolonged treatment of cells with TPA downregulates protein kinase C and in our study, the 24 h treatment of WB cells with TPA resulted in no inhibition of dye-coupling (Figure 2 ). In addition, when WB-F344 and WB-a/32-10 cells were treated simultaneously with TPA and a highly specific inhibitor of protein kinase C, bis-indoylmaleimide (2 µM), the inhibitor completely prevented the blockage of GJIC induced by TPA (Figure 3) . 
TPA effects on connexin expression and immunostaining
Inhibition of GJIC by TPA in WB-F344 and WB-a/32-10 cells could result from changes in connexin mRNA or protein content or protein phosphorylation. To examine the effects of TPA on connexin mRNA content, total RNA was isolated from cells treated with TPA for 2 h and analyzed by Northern blotting. Figure 4 shows that WB-F344 cells (controls) expressed mostly Cx43 mRNA and a lesser amount of Cx26, whereas WB-a/32-10 cells expressed both Cx43 and Cx32 mRNA. Treatment with TPA had no significant effect on the levels of these messengers.
To determine if treatment with TPA altered the phosphorylation pattern or content of connexins, membrane-enriched fractions of TPA-treated cells were subjected to Western blotting. Figure 5 shows that WB-F344 cells (controls) expressed multiple forms of Cx43, which appeared on the blot as three bands that migrated at~42-46 kDa and are designated Cx43-NP, Cx43-P1 and Cx43-P2 ( Figure 5A, lane 1) . Cx43-NP represents non-phosphorylated Cx43 whereas Cx43-P1 and Cx43-P2 are phosphorylated forms (14, 28) . Treatment of WB-F344 cells with TPA decreased the Cx43-NP and Cx43-P1 forms with a concomitant appearance of a hyperphosphorylated form, Cx43-P3, which migrated at 48 kDa ( Figure 5A , lane 2). In contrast, WB-aB1 and WB-a/32-10 cells expressed only Cx43-NP and Cx43-P1, and TPA did not affect their levels or induce a hyperphosphorylated form ( Figure 5B and C) . WBa/32-10 cells also expressed Cx32, which appeared as a single band that migrated at~27 kDa ( Figure 5D ). This protein was also detected in primary cultured rat hepatocytes as a single band at 27 kDa ( Figure 5E ). TPA did not alter the content or mobility of Cx32 in either type of cell.
We have shown previously that TPA treatment of WB-F344 cells induced the cytoplasmic internalization of gap junctions containing Cx43 (14, 29) . To determine if gap junctions composed of Cx32 are also internalized, we immunostained WB-F344 and WB-a/32-10 cells with Cx43 and Cx32 antibodies. As seen in Figure 6 , Cx43 staining in control WB-F344 cells, appeared as spots and streaks localized principally at cell-cell interfaces. Treatment with TPA decreased staining at the cellcell interfaces with a concomitant appearance of many spots in the cytoplasm. In contrast, Cx43 staining in WB-a/32-10 cells was also localized to the plasma membrane, but was diffusely organized. These cells also stained positively for Cx32, which appeared at cell-cell interfaces. Treatment of WB-a/32-10 cells with TPA did not alter the intensity or location of Cx43 or Cx32 staining.
Effects of non-phorbol ester tumor promoters
To further test the cell-specific effects of tumor promoters on hepatic cell GJIC, we used two liver tumor promoters, DDT and PB. DDT has been reported to inhibit GJIC in many types of cells including WB-F344 cells and hepatocytes, but PB only inhibited GJIC in hepatocytes and was ineffective in WB-F344 cells (12, 13, (30) (31) (32) . We investigated whether DDT and PB could inhibit GJIC in Cx32-expressing WB-a/32-10 cells and if this was similar to the effects in WB-F344 cells or hepatocytes. Treatment of WB-F344 cells, WB-a/32-10 cells and hepatocytes with DDT inhibited GJIC in a dose-responsive manner in all three cell types ( Figure 7A ). Compared with hepatocytes, the two WB cell types were more sensitive. In contrast, PB inhibited GJIC in hepatocytes but had no effect in WB-F344 or WB-a/32-10 cells ( Figure 7B ). Moreover, treatment with the protein kinase C inhibitor, bis-indolylmaleimide, did not block the inhibition by DDT in these three types of cells or by PB in hepatocytes (data not shown).
Western blot analyses indicated that DDT caused a reduction in Cx43-P2 content in WB-F344 cells, but did not alter Cx43 or Cx32 content in the other cells ( Figure 5 ). PB did not affect Cx43 or Cx32 content or gel mobility in any of the cells ( Figure 5 ). Furthermore, immunostaining indicated that Cx43 staining was reduced dramatically by DDT in WB-F344 cells, but neither Cx43 nor Cx32 staining were affected by DDT or PB in WB-a/32-10 cells or hepatocytes.
Discussion
This study has shown that TPA strongly inhibited GJIC in WB cells whether cell-cell coupling was mediated by Cx43 or Cx32, but that the phorbol ester did not inhibit GJIC in primary cultured hepatocytes that expressed Cx32. The results also indicate that these inhibitory effects of TPA on Cx43 and Cx32-mediated GJIC in WB cells involved protein kinase C. This conclusion was supported by the fact that downregulation of the kinase by chronic exposure to TPA (reference 8 and Figure 2 ) resulted in no inhibition of GJIC and that a specific inhibitor of the kinase, bis-indolylmaleimide, blocked the inhibitory effects of TPA ( Figure 3) . Thus, activation of protein kinase C by TPA can inhibit both Cx43 and Cx32-mediated GJIC. These results support previous findings and provide new information. TPA has been widely reported to inhibit Cx43-mediated GJIC in a protein kinase C-dependent manner in many types of cells (3) (4) (5) (6) . TPA also has been reported recently to block GJIC in Cx32-transfected HeLa cells (33) . This is in contrast to reports indicating that protein kinase C phosphorylation of hepatocyte Cx32 reduced its degradation (19) and might increase hepatocyte GJIC (18) . Our data agree with Mazzoleni et al. (33) that TPA can block Cx32-mediated GJIC in non-hepatocytic cells and demonstrate for the first time that this involves protein kinase C. It is still unclear, however, why TPA does not block GJIC in hepatocytes, but does so in other types of cells. This may be due to cell-specific expression or activation of protein kinase C isozymes or to differences in Cx32 phosphorylation. Studies are underway to address these possibilities.
Besides blocking dye-coupling, TPA also induced the internalization of Cx43-containing gap junctions ( Figure 6 ) and the appearance of a novel hyperphosphorylated Cx43 isoform, Cx43-P3, in WB-F344 cells (references 14,29 and Figure 5 ). These effects have also been related to protein kinase C activation (14) . In contrast, no Cx43 hyperphosphorylation or gap junction internalization were seen in WB-aB1 and WB-a/ 32-10 cells, despite the fact these cells also expressed Cx43 (Figures 5 and 6 ). These cell-specific differences were not due to the inability of TPA to activate protein kinase C in WB-a/ 32-10 cells, because TPA inhibited Cx32-mediated GJIC in these cells in a protein kinase C-dependent manner (Figures 2  and 3) . Instead, one explanation is that WB-F344 cells expressed Cx43-P2 whereas WB-aB1 and WB-a/32-10 cells did not. This form of the protein has been localized to large gap junction maculae or plaques by Musil and co-workers (28) and is similarly localized in WB-F344 cells (30) . In these cells, Cx43-P2 could be the target for protein kinase C phosphorylation to Cx43-P3 and this could trigger the internalization of the large gap junction plaques. In WB-aB1 and WB-a/32-10 cells, these changes might not be seen because the cells lacked Cx43-P2 and large junctional plaques. This explanation is difficult to reconcile, however, with the fact that the contents of Cx43-NP and Cx43-P1, but not Cx43-P2, were reduced by TPA treatment in association with the appearance of Cx43-P3 in WB-F344 cells ( Figure 5 ). Clearly, these changes in Cx43 phosphorylation and localization in response to TPA are complex and require further study. The WB-F344 and WB-aB1 cell lines will be useful to investigate these relationships.
In contrast to TPA, the non-phorbol ester tumor promoter, PB, did not inhibit Cx43 or Cx32-mediated GJIC in WB-F344 and WB-a/32-10 cells, but did inhibit GJIC in primary cultured hepatocytes (Figure 7 ). This inhibition was not mediated by protein kinase C. Our previous studies have shown that the inhibition of hepatocyte GJIC by PB involves the cytochrome P450 mixed function oxidase system (MFOS) (32) . Inhibition of MFOS activity using SKF-525A prevented the inhibition of hepatocyte GJIC by PB, which suggested that P450-mediated metabolism was involved (32) . These results were confirmed by others (34, 35) . Unlike hepatocytes, liver epithelial cells have little MFOS activity (36) and this might explain why PB was an ineffective inhibitor of GJIC in WB cells.
In contrast to PB and TPA, DDT blocked GJIC in WB-F344 cells, WB-a/32-10 cells and primary cultured hepatocytes ( Figure 7 ). The mechanism of inhibition of GJIC by DDT is not known, but the present data and a previous study (37) indicate that protein kinase C was not involved. Instead, inhibition was related to DDT elevation of intracellular Ca 2ϩ (38) which can block gap junction channels (39) . Another group, however, did not detect an increase in intracellular Ca 2ϩ levels in DDT-treated WB-F344 cells (37) . Our previous work suggested a mechanism involving altered cAMP metabolism (40) . Elevation of cAMP levels has been reported to increase both the formation and permeability of Cx43 and Cx32-containing gap junctions (39) . The kinase directly phosphorylated Cx32 (41) and may similarly phosphorylate Cx43 (42) . We reported (40) that DDT reduced cAMP levels in hepatocytes and that the inhibition of coupling could be prevented by a cell permeable cAMP analog. Thus, DDT might block Cx32 and Cx43-mediated GJIC in WB cells and hepatocytes by altering intracellular Ca 2ϩ and/or cAMP levels. Similarly, the inhibition by PB might also involve cAMP (40) .
We have reported that DDT treatment of WB-F344 cells induced the internalization and degradation of gap junctions in lysosomes (43) . These effects were correlated with a reduction of the cellular content of Cx43-P2. In the current study, DDT also reduced Cx43-containing gap junctions and Cx43-P2 content in WB-F344 cells, but no changes in Cx43 levels or immunostaining were seen in WB-aB1 and WB-a/ 32-10 cells (Figures 5 and 6 ). In addition, Cx32 content and immunostaining were not affected in WB-a/32-10 cells or hepatocytes. These results suggest that DDT induces the internalization and degradation of Cx43-P2 containing junctions, but not those comprised of other Cx43 forms or Cx32. Furthermore, the mechanism of DDT-induced internalization of Cx43-containing gap junctions appears to be different from TPA and does not involve protein kinase C.
For the limited sets of cells and tumor promoters studied here, our data indicate that the effects of tumor promoters on GJIC are dependent upon the cellular background rather than the type of connexin forming the gap junction. These types of studies, as well as in vivo ones, should be carried out with other types of cells, connexins and tumor promoters. The results will provide new information about mechanisms of promoter inhibition of GJIC and cell and organotypic tumor promotion. Furthermore, such in vivo/in vitro studies will further elucidate the cell-and connexin-specific effects of tumor promoters on GJIC in preneoplastic cells as they evolve genetically and epigenetically towards neoplasia.
